PDLIM7 and carcinoma: On the other hand, it has been reported by several investigations that LMP1, LMP2A, EBNA3C, and EBNA1 oncoproteins of EBV can enhance cancer progression via the modulation of EMT in human carcinomas including NPCs (20, 53–56).